Template:Babesiosis Antibiotics: Difference between revisions
(Convert to AntibioticDose with disease=Babesiosis for SMW linking) |
(Add Quinine Pediatric AntibioticDose entry from original Quinine page dosing) |
||
| Line 9: | Line 9: | ||
===Pediatrics=== | ===Pediatrics=== | ||
*{{AntibioticDose|disease=Babesiosis|drug=Clindamycin|dose=20-25mg/kg/day x 7-10 days|context=Pediatric|population=Pediatric}} | *{{AntibioticDose|disease=Babesiosis|drug=Clindamycin|dose=20-25mg/kg/day x 7-10 days|context=Pediatric|population=Pediatric}} | ||
*{{AntibioticDose|disease=Babesiosis|drug=Quinine|dose=8mg/kg PO q8h x 7-10 days (Max: 648mg/dose)|context=Severe parasitemia with Clindamycin|population=Pediatric}} | |||
Revision as of 12:16, 20 March 2026
Each regimen is for 10 days duration and option 1 is often used for mild parasitemia <4% with option two for severe cases with >4% parasite load
Option 1
Atovaquone 750mg BID x 10 days and Azithromycin 500-1000mg day 1 then 250-1000mg daily x 10 days[1]
Option 2
- Clindamycin 600mg PO q8hrs x 7-10 days (or 300-600mg IV q6hrs)
- Give with Quinine 650mg TID
Pediatrics
- Clindamycin 20-25mg/kg/day x 7-10 days
- Quinine 8mg/kg PO q8h x 7-10 days (Max: 648mg/dose)
- ↑ Krause PJ, Lepore T, Sikand VK, Gadbaw J Jr, Burke G, Telford SR 3rd, et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med. Nov 16 2000;343(20):1454-8.